Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

NT-proBNP Age-Adjusted Thresholds

NT-proBNP Age-Adjusted Thresholds: Interprets acute dyspnea using age-stratified NT-proBNP cutoffs (ICON trial) to distinguish heart failure from other causes.

65 Years
pg/mL
Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Patients presenting to the emergency department or acute care setting with undifferentiated dyspnea.
To rapidly rule-out or rule-in Acute Heart Failure (AHF) as the primary etiology of the patient's presentation.
Evaluation of patients with a high degree of clinical suspicion for congestive heart failure exacerbation.

Critical Exclusion

These thresholds are NOT applicable for the standard BNP assay (B-type Natriuretic Peptide). They are specific to the N-terminal fragment (NT-proBNP), which has higher absolute values and different clearance characteristics.

How it Works

Why Age Matters

NT-proBNP is cleared primarily by the kidneys. As humans age, physiological renal clearance slowly declines, and myocardial compliance decreases (even in the absence of heart failure), leading to higher baseline NT-proBNP levels. Using a single threshold for all ages would lead to an unacceptably high false-positive rate in elderly patients.

The ICON Thresholds

Age GroupRule-Out (AHF Unlikely)Rule-In (AHF Likely)
All Ages< 300 pg/mLN/A
< 50 yearsN/A> 450 pg/mL
50 - 75 yearsN/A> 900 pg/mL
> 75 yearsN/A> 1800 pg/mL

Clinical Pearls

The "Grey Zone"

Values between 300 and the age-adjusted rule-in threshold are considered the "Grey Zone." These results are indeterminate and require clinical correlation, echocardiography, and consideration of alternative diagnoses (e.g., Pulmonary Embolism, Sepsis, AFib, or Chronic Kidney Disease).

The Obesity Paradox

Obese patients (BMI > 30) often have paradoxically lower NT-proBNP levels (~50% lower on average) due to increased peptide clearance by adipose tissue receptors. In a severely obese patient, an NT-proBNP of 250 pg/mL may still represent heart failure despite being below the standard rule-out threshold.

Renal Influence

In patients with advanced Chronic Kidney Disease (eGFR < 60), baseline NT-proBNP is chronically elevated. Clinical judgment should supersede absolute thresholds in these patients, though a value < 300 still remains a powerful rule-out tool.

The Evidence

Key Reference

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study

Januzzi JL et al. • European Heart Journal. 2006;27(3):330-7. The landmark study validating the age-adjusted cutoffs.

The NT-proBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study

Januzzi JL et al. • The American Journal of Cardiology. 2005;95(8):948-54

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.